细胞色素P450酶：其与选择性5-羟色胺再摄取抑制剂相互作用的解读。第一部分。 - Suppr

Suppr

超能文献

Cytochrome P450 enzymes: interpretation of their interactions with selective serotonin reuptake inhibitors. Part I.

作者信息

Harvey A T, Preskorn S H

机构信息

Psychiatric Research Institute, University of Kansas School of Medicine, Wichita 67214-2878, USA.

出版信息

J Clin Psychopharmacol. 1996 Aug;16(4):273-85. doi: 10.1097/00004714-199608000-00002.

DOI:10.1097/00004714-199608000-00002

PMID:8835702

Abstract

摘要

相似文献

Cytochrome P450 enzymes: interpretation of their interactions with selective serotonin reuptake inhibitors. Part I.细胞色素P450酶：其与选择性5-羟色胺再摄取抑制剂相互作用的解读。第一部分。

J Clin Psychopharmacol. 1996 Aug;16(4):273-85. doi: 10.1097/00004714-199608000-00002.

Cytochrome P450 enzymes: interpretation of their interactions with selective serotonin reuptake inhibitors. Part II.细胞色素P450酶：其与选择性5-羟色胺再摄取抑制剂相互作用的解读。第二部分。

J Clin Psychopharmacol. 1996 Oct;16(5):345-55. doi: 10.1097/00004714-199610000-00002.

Clinically relevant pharmacology of selective serotonin reuptake inhibitors. An overview with emphasis on pharmacokinetics and effects on oxidative drug metabolism.选择性5-羟色胺再摄取抑制剂的临床相关药理学。重点关注药代动力学及对药物氧化代谢影响的综述。

Clin Pharmacokinet. 1997;32 Suppl 1:1-21. doi: 10.2165/00003088-199700321-00003.

Inhibition of phenytoin hydroxylation in human liver microsomes by several selective serotonin re-uptake inhibitors.几种选择性5-羟色胺再摄取抑制剂对人肝微粒体中苯妥英羟化作用的抑制

Epilepsy Res. 2001 Apr;44(1):71-82. doi: 10.1016/s0920-1211(00)00203-5.

Identification of cytochrome P450 isoforms involved in the metabolism of paroxetine and estimation of their importance for human paroxetine metabolism using a population-based simulator.鉴定细胞色素 P450 同工酶在帕罗西汀代谢中的作用，并使用基于人群的模拟器评估其对人体帕罗西汀代谢的重要性。

Drug Metab Dispos. 2010 Mar;38(3):376-85. doi: 10.1124/dmd.109.030551. Epub 2009 Dec 10.

(R)-, (S)-, and racemic fluoxetine N-demethylation by human cytochrome P450 enzymes.人细胞色素P450酶对（R）-、（S）-和消旋氟西汀的N-去甲基化作用。

Drug Metab Dispos. 2000 Oct;28(10):1187-91.

Human cytochromes mediating N-demethylation of fluoxetine in vitro.体外介导氟西汀N-去甲基化的人细胞色素

Psychopharmacology (Berl). 1997 Aug;132(4):402-7. doi: 10.1007/s002130050362.

O-Dealkylation of fluoxetine in relation to CYP2C19 gene dose and involvement of CYP3A4 in human liver microsomes.氟西汀在人肝微粒体中的 O-去烷基化与 CYP2C19 基因剂量及 CYP3A4 的参与关系

J Pharmacol Exp Ther. 2002 Jan;300(1):105-11. doi: 10.1124/jpet.300.1.105.

Analytical methods for the quantitative determination of selective serotonin reuptake inhibitors for therapeutic drug monitoring purposes in patients.用于治疗药物监测目的的患者体内选择性5-羟色胺再摄取抑制剂定量测定的分析方法。

J Chromatogr B Biomed Appl. 1996 Nov 8;686(1):51-63. doi: 10.1016/s0378-4347(96)00338-6.

Economic consequences of selective serotonin reuptake inhibitor use with drugs also metabolized by the cytochrome P-450 system.选择性5-羟色胺再摄取抑制剂与同样经细胞色素P-450系统代谢的药物联合使用的经济后果。

Clin Ther. 1998 Jul-Aug;20(4):780-96. doi: 10.1016/s0149-2918(98)80141-0.

引用本文的文献

The Role of Metabolites of Antidepressants in the Treatment of Depression.抗抑郁药代谢物在抑郁症治疗中的作用。

CNS Drugs. 1997 Apr;7(4):273-312. doi: 10.2165/00023210-199707040-00003.

Antidepressants relevant to oral and maxillofacial surgical practice.与口腔颌面外科手术实践相关的抗抑郁药。

Ann Maxillofac Surg. 2013 Jul;3(2):160-6. doi: 10.4103/2231-0746.119233.

Metabolism of N-methyl, N-propargylphenylethylamine: studies with human liver microsomes and cDNA expressed cytochrome P450 (CYP) enzymes.N-甲基-N-炔丙基苯乙胺的代谢：用人肝微粒体和cDNA表达的细胞色素P450（CYP）酶进行的研究。

Cell Mol Neurobiol. 2007 Mar;27(2):179-90. doi: 10.1007/s10571-006-9085-1. Epub 2006 Dec 8.

Heart and mind: (2) psychotropic and cardiovascular therapeutics.心脏与精神：（2）精神药物与心血管治疗学

Postgrad Med J. 2005 Jan;81(951):33-40. doi: 10.1136/pgmj.2003.015230.

Paradigms for pharmacologic use as a treatment component in feline behavioral medicine.作为猫科动物行为医学治疗组成部分的药物使用范例。

J Feline Med Surg. 2004 Feb;6(1):29-42. doi: 10.1016/j.jfms.2003.09.009.

The Comorbidity of Major Depression and Anxiety Disorders: Recognition and Management in Primary Care.重度抑郁症与焦虑症的共病：基层医疗中的识别与管理

Prim Care Companion J Clin Psychiatry. 2001 Dec;3(6):244-254. doi: 10.4088/pcc.v03n0609.

Role of pharmacogenomics in individualising treatment with SSRIs.药物基因组学在选择性5-羟色胺再摄取抑制剂个体化治疗中的作用。

CNS Drugs. 2003;17(3):143-51. doi: 10.2165/00023210-200317030-00001.

Metabolism of anxiolytics and hypnotics: benzodiazepines, buspirone, zoplicone, and zolpidem.抗焦虑药和催眠药的代谢：苯二氮䓬类、丁螺环酮、佐匹克隆和唑吡坦。

Cell Mol Neurobiol. 1999 Aug;19(4):533-52. doi: 10.1023/a:1006943009192.

Metabolism and pharmacokinetics of selective serotonin reuptake inhibitors.选择性5-羟色胺再摄取抑制剂的代谢与药代动力学

Cell Mol Neurobiol. 1999 Aug;19(4):443-66. doi: 10.1023/a:1006934807375.

Metabolism of some "second"- and "fourth"-generation antidepressants: iprindole, viloxazine, bupropion, mianserin, maprotiline, trazodone, nefazodone, and venlafaxine.一些“第二代”和“第四代”抗抑郁药的代谢：茚满二酮、维洛沙嗪、安非他酮、米安色林、马普替林、曲唑酮、奈法唑酮和文拉法辛。

Cell Mol Neurobiol. 1999 Aug;19(4):427-42. doi: 10.1023/a:1006953923305.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验